Julia C. Greenland

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.

Journal: The Lancet. Neurology

Published: July 09, 2025

Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease.

Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: June 25, 2025

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

Journal: NPJ Parkinson's disease

Published: November 18, 2024

Peripheral-central immune crosstalk in Parkinson's disease and its association with clinical severity.

Peripheral-central immune crosstalk in Parkinson's disease and its association with clinical severity.

Journal: Brain, behavior, and immunity

Published: November 13, 2024

Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents.

Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents.

Journal: Journal of Parkinson's disease

Published: September 27, 2024

The profile of gastrointestinal dysfunction in prodromal to late-stage Parkinson's disease.

The profile of gastrointestinal dysfunction in prodromal to late-stage Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 05, 2024

Validation of a 5-Year Prognostic Model for Parkinson's Disease.

Validation of a 5-Year Prognostic Model for Parkinson's Disease.

Journal: Movement disorders clinical practice

Published: July 08, 2024

Natural killer cells have an activated profile in early Parkinson's disease.

Natural killer cells have an activated profile in early Parkinson's disease.

Journal: Journal of neuroimmunology

Published: April 19, 2023

The dilemma between milestones of progression versus clinical scales in Parkinson's disease.

The dilemma between milestones of progression versus clinical scales in Parkinson's disease.

Journal: Handbook of clinical neurology

Published: February 16, 2023

Huntington's disease: diagnosis and management.

Huntington's disease: diagnosis and management.

Journal: Practical neurology

Published: July 14, 2021

The Gastrointestinal Dysfunction Scale for Parkinson's Disease.

The Gastrointestinal Dysfunction Scale for Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: January 27, 2021

Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.

Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.

Journal: BMJ open

Published: November 25, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026